Gloucestershire Hospitals NHS Foundation Trust awarded "Send Away Test for Oncotype DX Breast Recurrence Score" to Exact Sciences UK, Ltd., with a value of £229,500 (08 October 2026).
Provision of Oncotype DX Breast Recurrence Score via a genomic assay that provides a personalised insight into an individual patient's breast cancer biology.
A weekly round-up of new UK public sector contracts. No spam, unsubscribe any time.